Publications by authors named "Joshua D Snook"

Claim this Profile
A
A Preclinical Safety Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells for Macular Degeneration.
John L Mazzilli, Joshua D Snook, Ken Simmons, Aleksey Y Domozhirov, Charles A Garcia

J Ocul Pharmacol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized culture of retinal ganglion cells and amacrine cells from adult mice.
Yong H Park, Joshua D Snook, Iris Zhuang, Guofu Shen, Benjamin J Frankfort

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic profiles of retinal ganglion cells are defined by the magnitude of intraocular pressure elevation in adult mice.
Yong H Park, Joshua D Snook, Edwin J Ostrin, Sangbae Kim, Rui Chen

Sci Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of Cocaine-Evoked Hyperactivity by Self-Adjuvanting and Multivalent Peptide Nanofiber Vaccines.
Jai S Rudra, Ye Ding, Harshini Neelakantan, Chunyong Ding, Rajagopal Appavu, Joshua D Snook

ACS Chem Neurosci· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide nanofiber-CaCO composite microparticles as adjuvant-free oral vaccine delivery vehicles.
Joshua D Snook, Charles B Chesson, Alex G Peniche, Sara M Dann, Adriana Paulucci

J Mater Chem B· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the Magnitude of Antibody Responses through Biomaterial Stereochemistry.
Rajagopal Appavu, Charles B Chesson, Alexey Y Koyfman, Joshua D Snook, Frederick J Kohlhapp

ACS Biomater Sci Eng· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade.
Frederick J Kohlhapp, Joseph R Broucek, Tasha Hughes, Erica J Huelsmann, Jevgenijs Lusciks, Joshua D Snook

J Immunother Cancer· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis